KOWA CO. LTD.
5.20
EUR
+0.05
(+0.97%)
ISIN
JP3292900002
Return %
Stock
S&P 500
1Y
19.27
14.20
3Y
-29.73
81.12
5Y
- -
68.34
Capital Structure
JPY
•
in mil. unless spec.Working Capital
JPY
•
in mil. unless spec.Growth Rates
JPY
•
in mil. unless spec.Quarterly Revenue
JPY
•
in mil. unless spec.Quarterly Earnings Per Share
JPY
•
in mil. unless spec.Quarterly Dividends Per Share
JPY
•
in mil. unless spec.Company Description
- CEO
- Hiroshi Yashiro
- Full Time Employees
- 211
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- Kaizan-cho 3-159-1 Osaka OS Japan 590-0982
- IPO Date
- Nov 28, 2017
- Website
- kowa-seisakusho.co.jp
- Similar Companies
- Business
- Kowa Co., Ltd. is a diversified Japanese enterprise primarily engaged in the manufacturing and sales of nursing care products and welfare equipment, pharmaceuticals, trading, and industrial technology solutions. The company offers a broad range of core products including nursing care and welfare equipment such as walking carts, walking aids, silver carts, handrails, walking canes, bath and toilet-related products, and life-support devices. Kowa also manufactures and sells over-the-counter (OTC) and prescription drugs, medical devices including ophthalmic diagnostic instruments, retinal cameras, and related medical diagnostic equipment. Additional business segments comprise trading of textiles, machinery, construction materials, chemicals, and commodities, as well as manufacturing and sales of factory automation (FA) units, security vision units, robotics system integration, lenses and cameras hardware, embedded software, AI systems, energy saving and energy creating solutions, and environmentally friendly architectural construction. The company operates globally with strategic offices in Japan, the United States, Europe, and Asia, with its headquarters located in Nagoya, Japan. Founded in 1894, Kowa continues to hold a prominent position in healthcare, pharmaceuticals, industrial technologies, and trading sectors. Recent major developments include a strategic capital and business alliance with SPACE WALKER in 2025 aimed at advancing hydrogen energy technology. This partnership focuses on the mass production of next-generation composite high-pressure gas tanks to reduce hydrogen energy transportation costs, supporting decarbonization and energy industry sustainability. Kowa is also conducting feasibility studies for ammonia co-firing technology in India and exploring green fuel value chains in collaboration with the Japan-India Clean Energy Partnership. Additionally, in 2023, Kowa expanded its technological portfolio by integrating AI and advanced robotics through the acquisition of and alliance with Kowa Skymech, enhancing its capabilities in automation and cutting-edge technological solutions. The company has also been active in launching new pharmaceutical products and strengthening distribution partnerships, such as expanding the distribution of its triglycerides-lowering drug Parmodia in Southeast Asia. These initiatives reflect Kowa's strategic shift towards sustainable technologies, healthcare innovation, and expansion across global markets. Industry-wise, Kowa operates in healthcare and welfare products, pharmaceutical manufacturing and sales, industrial machinery and automation, chemical trading, and technologically advanced manufacturing. Its target markets include medical institutions, nursing care providers, industrial clients, and international trading partners. Kowa has subsidiaries and affiliates supporting its diversified operations across Japan, Europe, the Americas, and Asia. The company's sustained investment in R&D and strategic alliances underscores its commitment to innovation and growth while maintaining a strong foundation in its over 130-year history.